SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-22-021033
Filing Date
2022-05-27
Accepted
2022-05-27 16:35:32
Documents
14
Period of Report
2022-05-24
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc10038174_8k.htm   iXBRL 8-K 30309
2 EXHIBIT 99.1 brhc10038174_ex99-1.htm EX-99.1 10594
6 image00001.jpg GRAPHIC 6110
  Complete submission text file 0001140361-22-021033.txt   191246

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA btx-20220524.xsd EX-101.SCH 3929
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE btx-20220524_lab.xml EX-101.LAB 22544
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE btx-20220524_pre.xml EX-101.PRE 16047
8 EXTRACTED XBRL INSTANCE DOCUMENT brhc10038174_8k_htm.xml XML 4245
Mailing Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220
Business Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220 (212) 582-1199
Brooklyn ImmunoTherapeutics, Inc. (Filer) CIK: 0000748592 (see all company filings)

IRS No.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-11460 | Film No.: 22978268
SIC: 2834 Pharmaceutical Preparations